EUVIMEDEUVIMED entdecken
Crossref

Drift Parameter Based Sample Size Determination in Multi‐Stage Bayesian Randomized Clinical Trials

Yueyang Han, Haolun Shi, Jiguo Cao, Ruitao Lin iD

Pharmaceutical Statistics · 2025

DOI: 10.1002/pst.70037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Statistics, 2025. Verfasst von Yueyang Han und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Statistics and Actuarial Science, Simon Fraser University, Burnaby, British Columbia, Canada. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Clinical Trials, Phase II as Topic, Research Design. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Natural Sciences and Engineering Research Council of Canada, Collaborative Research Team sponsored by CANSSI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sample size determination in Bayesian randomized phase II trial design often relies on computationally intensive search methods, presenting challenges in terms of feasibility and efficiency. We propose a novel approach that greatly reduces the computing time of sample size calculations for Bayesian trial designs. Our approach innovatively connects group sequential design with Bayesian trial design and leverages the proportional relationship between sample size and the squared drift parameter. This results in a faster algorithm. By employing regression analysis, our method can accurately pinpoint the required sample size with significantly reduced computational burden. Through theoretical justification and extensive numerical evaluations, we validate our approach and illustrate its efficiency across a wide range of common trial scenarios, including binary endpoint with Beta‐Binomial model, normal endpoint, binary/ordinal endpoint under Bayesian generalized linear model, and survival endpoints under Bayesian piecewise exponential models. To facilitate the use of our methods, we create an R package named “BayesSize” on GitHub.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Randomized Controlled Trials as TopicClinical Trials, Phase II as TopicResearch DesignBayes TheoremHumansSample SizeAlgorithmsModels, StatisticalLinear Models

Stichwörter der Autor:innen

Bayesian designmulti‐stage designphase II clinical trialposterior probabilityrandomized trialsample size

Autor:innen und Institutionen

  • Department of Statistics and Actuarial Science, Simon Fraser University, Burnaby, British Columbia, Canada.
  • Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

ORCID-Profile: Ruitao Lin

Förderung

  • Natural Sciences and Engineering Research Council of Canada
  • Collaborative Research Team sponsored by CANSSI

Zitieren

APA

Han, Y., Shi, H., Cao, J., & Lin, R. (2025). Drift Parameter Based Sample Size Determination in Multi‐Stage Bayesian Randomized Clinical Trials. Pharmaceutical Statistics. https://doi.org/10.1002/pst.70037

Vancouver

Han Y, Shi H, Cao J, Lin R. Drift Parameter Based Sample Size Determination in Multi‐Stage Bayesian Randomized Clinical Trials. Pharmaceutical Statistics. 2025. doi:10.1002/pst.70037

BibTeX
@article{Han2025,
  author = {Han, Yueyang and Shi, Haolun and Cao, Jiguo and Lin, Ruitao},
  title = {Drift Parameter Based Sample Size Determination in Multi‐Stage Bayesian Randomized Clinical Trials},
  journal = {Pharmaceutical Statistics},
  year = {2025},
  doi = {10.1002/pst.70037}
}
Kostenlos starten →